CR20190127A - Métodos para detectar aav - Google Patents
Métodos para detectar aavInfo
- Publication number
- CR20190127A CR20190127A CR20190127A CR20190127A CR20190127A CR 20190127 A CR20190127 A CR 20190127A CR 20190127 A CR20190127 A CR 20190127A CR 20190127 A CR20190127 A CR 20190127A CR 20190127 A CR20190127 A CR 20190127A
- Authority
- CR
- Costa Rica
- Prior art keywords
- determining
- particles
- aav
- heterogeneity
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/075—Adenoviridae
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
En la presente memoria se proporcionan métodos para determinar el serotipo de una partícula de virus y/o para determinar la heterogeneidad de una partícula de virus (p. ej., una partícula de AAV). En otras realizaciones, la invención proporciona métodos para determinar la heterogeneidad de partículas de AAV. En algunos aspectos, la invención proporciona partículas virales (p. ej., partículas de AAVr) con estabilidad mejorada y/o eficiencia de la transducción mejorada mediante el incremento de la acetilación y/o desamidación de las proteínas de la cápsideProvided herein are methods for determining the serotype of a virus particle and/or or determining the heterogeneity of a virus particle (e.g., an AAV particle). In other embodiments, the invention provides methods to determine the heterogeneity of AAV particles. In some aspects, the invention provides viral particles (e.g., rAAV particles) with improved stability and/or improved transduction efficiency by increasing the acetylation and/or deamidation of capsid proteins.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662375314P | 2016-08-15 | 2016-08-15 | |
| PCT/US2017/046814 WO2018035059A1 (en) | 2016-08-15 | 2017-08-14 | Methods for detecting aav |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20190127A true CR20190127A (es) | 2019-06-25 |
Family
ID=59762045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20190127A CR20190127A (es) | 2016-08-15 | 2017-08-14 | Métodos para detectar aav |
Country Status (22)
| Country | Link |
|---|---|
| US (5) | US11698377B2 (es) |
| EP (2) | EP3851449A1 (es) |
| JP (3) | JP7021191B2 (es) |
| KR (5) | KR102922101B1 (es) |
| CN (2) | CN118688363A (es) |
| AU (2) | AU2017312951B2 (es) |
| CA (1) | CA3033856A1 (es) |
| CL (2) | CL2019000392A1 (es) |
| CR (1) | CR20190127A (es) |
| CY (1) | CY1124364T1 (es) |
| DK (1) | DK3497207T3 (es) |
| ES (1) | ES2863674T3 (es) |
| HU (1) | HUE053747T2 (es) |
| IL (3) | IL264819B2 (es) |
| MA (1) | MA55748A (es) |
| MX (2) | MX2019001938A (es) |
| PH (1) | PH12019500316A1 (es) |
| SG (2) | SG10201913002QA (es) |
| TN (1) | TN2019000047A1 (es) |
| TW (2) | TW202309068A (es) |
| WO (1) | WO2018035059A1 (es) |
| ZA (2) | ZA201900945B (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201508026D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Capsid |
| HUE053747T2 (hu) | 2016-08-15 | 2021-07-28 | Genzyme Corp | Eljárások AAV kimutatására |
| RS65241B1 (sr) * | 2017-02-28 | 2024-03-29 | Univ Pennsylvania | Vektor adeno-asociranih virusa (aav) iz podgrupe f i njegove upotrebe |
| JOP20190200A1 (ar) | 2017-02-28 | 2019-08-27 | Univ Pennsylvania | تركيبات نافعة في معالجة ضمور العضل النخاعي |
| EP3768695A4 (en) * | 2018-02-27 | 2022-04-06 | The Trustees of the University of Pennsylvania | NOVEL ADENO-ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS WITH REDUCED CAPSIID DEAMIDATION AND USES THEREOF |
| IL276859B2 (en) * | 2018-02-27 | 2025-12-01 | Univ Pennsylvania | Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor |
| EP3762500A1 (en) * | 2018-03-06 | 2021-01-13 | Voyager Therapeutics, Inc. | Insect cell manufactured partial self-complementary aav genomes |
| US11391707B2 (en) * | 2018-07-27 | 2022-07-19 | Waters Technologies Corporation | Liquid chromatography/mass spectrometry methods for the analysis of polar molecules |
| US12195745B2 (en) * | 2018-08-21 | 2025-01-14 | Massachusetts Eye And Ear Infirmary | Compositions and methods for modulating transduction efficiency of adeno-associated viruses |
| WO2020086893A1 (en) | 2018-10-25 | 2020-04-30 | Regeneron Pharmaceuticals, Inc. | Methods for analysis of viral capsid protein composition |
| ES2965341T3 (es) * | 2019-04-11 | 2024-04-12 | Regenxbio Inc | Métodos de cromatografía de exclusión por tamaño para la caracterización de composiciones de virus adenoasociados recombinantes |
| US11841352B2 (en) * | 2019-07-31 | 2023-12-12 | Thermo Finnigan Llc | Determination and correction of retention time and mass/charge shifts in LC-MS experiments |
| EP4085255A1 (en) * | 2020-01-03 | 2022-11-09 | Sarepta Therapeutics, Inc. | Methods for analyzing aav capsid proteins |
| WO2021155137A1 (en) | 2020-01-29 | 2021-08-05 | Genzyme Corporation | Modified adeno-associated viral capsid proteins for ocular gene therapy and methods of use thereof |
| CN111517359B (zh) * | 2020-04-23 | 2021-08-20 | 江南大学 | 一种手性硫化铜超粒子的合成方法 |
| RU2748540C1 (ru) * | 2021-02-08 | 2021-05-26 | Автономная некоммерческая образовательная организация высшего образования "Сколковский институт науки и технологий" | Способ детектирования вируса SARS-CoV-2 методом масс-спектрометрии |
| US20220268783A1 (en) * | 2021-02-19 | 2022-08-25 | Waters Technologies Corporation | Methods for peptide mapping of adeno-associated virus (aav) proteins |
| WO2022224965A1 (ja) * | 2021-04-20 | 2022-10-27 | 株式会社ユニバーサル・バイオサンプリング | 検体保持カード及びそれを用いた検体の検査方法 |
| JP2024525686A (ja) * | 2021-07-12 | 2024-07-12 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Aavカプシド比を決定するための液体クロマトグラフィーアッセイ |
| CA3225360A1 (en) * | 2021-07-12 | 2023-01-19 | Victoria COTHAM | Online native mass spectrometry methods for assaying viral particles |
| CN113552349B (zh) * | 2021-07-30 | 2022-07-19 | 上海勉亦生物科技有限公司 | Aav蛋白外壳的检测方法 |
| EP4462114A4 (en) * | 2022-01-06 | 2025-04-16 | FUJIFILM Corporation | Method and kit for identifying sugar-bound amino acid site in protein |
| US20250110119A1 (en) * | 2023-03-03 | 2025-04-03 | Sartorius Bioanalytical Instruments, Inc. | Methods for quantitating viral capsids |
| WO2024263520A1 (en) * | 2023-06-19 | 2024-12-26 | Regeneron Pharmaceuticals, Inc. | Host cell protein analysis for adeno-associated virus (aav)-based gene therapy |
| AU2024378556A1 (en) * | 2023-11-08 | 2026-05-21 | Oxford Biomedica (Us) Llc | Deamidation depleted adeno-associated virus product |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5540931A (en) | 1989-03-03 | 1996-07-30 | Charles W. Hewitt | Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants |
| US6204059B1 (en) * | 1994-06-30 | 2001-03-20 | University Of Pittsburgh | AAV capsid vehicles for molecular transfer |
| CA2264482A1 (en) | 1996-09-06 | 1998-03-12 | The Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6995006B2 (en) | 1997-09-05 | 2006-02-07 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6596535B1 (en) | 1999-08-09 | 2003-07-22 | Targeted Genetics Corporation | Metabolically activated recombinant viral vectors and methods for the preparation and use |
| US7465583B2 (en) | 2000-06-01 | 2008-12-16 | The University Of North Carolina At Chapel Hill | Duplexed parvovirus vectors |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| CN103589692B (zh) | 2001-11-13 | 2018-07-24 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| SI1496944T1 (sl) | 2002-05-01 | 2009-02-28 | Univ Florida | Izboljšani sistemi ekspresije RAAV za genetsko modifikacijo specifičnih kapsidnih proteinov |
| WO2004049385A2 (en) | 2002-11-22 | 2004-06-10 | Caprion Pharmaceuticals, Inc. | Constellation mapping and uses thereof |
| US7510872B2 (en) | 2003-02-26 | 2009-03-31 | Nationwide Children's Hospital | Recombinant adeno-associated virus production |
| JP4559429B2 (ja) | 2003-05-21 | 2010-10-06 | ジェンザイム・コーポレーション | 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法 |
| EP1486567A1 (en) | 2003-06-11 | 2004-12-15 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Improved adeno-associated virus (AAV) vector for gene therapy |
| US9441244B2 (en) * | 2003-06-30 | 2016-09-13 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| US8283151B2 (en) | 2005-04-29 | 2012-10-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes |
| PT3272872T (pt) | 2005-10-20 | 2020-06-26 | Uniqure Ip Bv | Vetores aav melhorados produzidos em células de insetos |
| US7588772B2 (en) | 2006-03-30 | 2009-09-15 | Board Of Trustees Of The Leland Stamford Junior University | AAV capsid library and AAV capsid proteins |
| EP2342567A1 (en) | 2008-09-19 | 2011-07-13 | Charité Universitätsmedizin Berlin | Identification and characterisation of recombinant viral gene therapy vectors |
| EP2396343B1 (en) | 2009-02-11 | 2017-05-17 | The University of North Carolina At Chapel Hill | Modified virus vectors and methods of making and using the same |
| JP5956331B2 (ja) | 2009-06-16 | 2016-07-27 | ジェンザイム・コーポレーション | 組換えaavベクターの改良された精製方法 |
| DK2561073T3 (en) | 2010-04-23 | 2016-12-12 | Univ Massachusetts | Aav vectors targeted to central nervous system and methods of use thereof |
| US20130217789A1 (en) * | 2010-09-03 | 2013-08-22 | North Carolina Central University | Biodegradable liquogel and ph sensitive nanocarriers |
| US8663624B2 (en) | 2010-10-06 | 2014-03-04 | The Regents Of The University Of California | Adeno-associated virus virions with variant capsid and methods of use thereof |
| CN103502458B (zh) | 2011-02-17 | 2016-11-16 | 宾夕法尼亚大学托管会 | 用于改变组织特异性和改善aav9-介导的基因转移的组合物和方法 |
| EP3795581A3 (en) | 2011-08-24 | 2021-06-09 | The Board of Trustees of the Leland Stanford Junior University | New avv capsid proteins for nucleic acid transfer |
| JP6342886B2 (ja) * | 2012-04-18 | 2018-06-13 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia | Aavカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法 |
| US20140017716A1 (en) * | 2012-07-11 | 2014-01-16 | Siscapa Assay Technologies, Inc. | Proteolytic digestion kit with dried reagents |
| GB201401707D0 (en) | 2014-01-31 | 2014-03-19 | Sec Dep For Health The | Adeno-associated viral vectors |
| WO2015137802A1 (en) * | 2014-03-10 | 2015-09-17 | Uniqure Ip B.V. | Further improved aav vectors produced in insect cells |
| HUE053747T2 (hu) | 2016-08-15 | 2021-07-28 | Genzyme Corp | Eljárások AAV kimutatására |
-
2017
- 2017-08-14 HU HUE17761362A patent/HUE053747T2/hu unknown
- 2017-08-14 SG SG10201913002QA patent/SG10201913002QA/en unknown
- 2017-08-14 CR CR20190127A patent/CR20190127A/es unknown
- 2017-08-14 EP EP20210237.2A patent/EP3851449A1/en active Pending
- 2017-08-14 KR KR1020247039853A patent/KR102922101B1/ko active Active
- 2017-08-14 CN CN202410630268.7A patent/CN118688363A/zh active Pending
- 2017-08-14 KR KR1020267003039A patent/KR20260036296A/ko active Pending
- 2017-08-14 KR KR1020237017707A patent/KR102738219B1/ko active Active
- 2017-08-14 ES ES17761362T patent/ES2863674T3/es active Active
- 2017-08-14 SG SG11201901221YA patent/SG11201901221YA/en unknown
- 2017-08-14 KR KR1020227025409A patent/KR102538037B1/ko active Active
- 2017-08-14 US US16/325,653 patent/US11698377B2/en active Active
- 2017-08-14 AU AU2017312951A patent/AU2017312951B2/en active Active
- 2017-08-14 MA MA055748A patent/MA55748A/fr unknown
- 2017-08-14 DK DK17761362.7T patent/DK3497207T3/da active
- 2017-08-14 EP EP17761362.7A patent/EP3497207B1/en active Active
- 2017-08-14 MX MX2019001938A patent/MX2019001938A/es unknown
- 2017-08-14 CN CN201780063531.7A patent/CN110168080B/zh active Active
- 2017-08-14 CA CA3033856A patent/CA3033856A1/en active Pending
- 2017-08-14 JP JP2019508235A patent/JP7021191B2/ja active Active
- 2017-08-14 IL IL264819A patent/IL264819B2/en unknown
- 2017-08-14 WO PCT/US2017/046814 patent/WO2018035059A1/en not_active Ceased
- 2017-08-14 TN TNP/2019/000047A patent/TN2019000047A1/en unknown
- 2017-08-14 KR KR1020197007381A patent/KR102425289B1/ko active Active
- 2017-08-14 IL IL312792A patent/IL312792B2/en unknown
- 2017-08-15 TW TW111138258A patent/TW202309068A/zh unknown
- 2017-08-15 TW TW106127648A patent/TWI781953B/zh active
-
2019
- 2019-02-13 CL CL2019000392A patent/CL2019000392A1/es unknown
- 2019-02-14 PH PH12019500316A patent/PH12019500316A1/en unknown
- 2019-02-14 ZA ZA2019/00945A patent/ZA201900945B/en unknown
- 2019-02-15 MX MX2023009081A patent/MX2023009081A/es unknown
- 2019-10-14 CL CL2019002912A patent/CL2019002912A1/es unknown
-
2021
- 2021-02-15 ZA ZA2021/01002A patent/ZA202101002B/en unknown
- 2021-03-24 CY CY20211100262T patent/CY1124364T1/el unknown
-
2022
- 2022-02-02 JP JP2022014629A patent/JP2022064980A/ja active Pending
-
2023
- 2023-05-22 US US18/321,542 patent/US12123880B2/en active Active
- 2023-11-30 JP JP2023202414A patent/JP2024023460A/ja active Pending
-
2024
- 2024-01-18 AU AU2024200349A patent/AU2024200349B2/en active Active
- 2024-08-12 US US18/801,293 patent/US20250027951A1/en active Pending
-
2025
- 2025-01-08 US US19/013,836 patent/US20250147042A1/en active Pending
- 2025-01-08 US US19/013,863 patent/US12298313B1/en active Active
- 2025-10-15 IL IL323969A patent/IL323969A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019001938A (es) | Metodos para detectar aav. | |
| MX395524B (es) | Proteinas de cápside modificadas para un suministro mejorado de vectores de parvovirus. | |
| UY36522A (es) | Ultracentrifugación analítica para la caracterización de partículas virales recombinantes | |
| MX388331B (es) | Variantes de virus adenoasociado y métodos de uso de estas | |
| WO2017066764A3 (en) | Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses | |
| EP3790567A4 (en) | LIVER-SPECIFIC TROPISM FROM ADENO-ASSOCIATED VIRUSES | |
| CL2017002731A1 (es) | Adenovirus oncolítico que codifica una proteína b7 | |
| MX384795B (es) | Vectores que comprenden secuencias de polinucleotidos rellenadoras/de relleno y metodos de uso. | |
| MX2019000882A (es) | Metodos de alta recuperacion escalables para una alta produccion de vector viral adenoasociado recombinante (raav) y vectores virales adenoasociados recombinantes (raav) producidos de este modo. | |
| EP3575398A4 (en) | ADENO-ASSOCIATED VIRUS (AAV) CAPSIDE PROTEIN MUTANT | |
| IL292625A (en) | Viruses with modified capsid proteins | |
| PE20150163A1 (es) | Composicion y metodos para una transferencia de genes altamente eficiente usando variantes capside aav | |
| BR112018071180A2 (pt) | métodos de reforço potência biológica de baculovirus system-produzido vírus adeno-associado recombinante | |
| CY1124707T1 (el) | Συνθεσεις και μεθοδοι για την επαγωγη ενισχυμενης ανοσοαποκρισης με χρηση φορεων ιων poxvirus (ευλογοϊων) | |
| MX2016010649A (es) | Vector de virus adeno-asociado. | |
| EP3347460A4 (en) | MODIFIED ONCOLYTIC VACCINIA VIRUSES WITH CYTOKIN AND CAR-BOXY-REFERENCE EXPRESSION AND METHOD OF USE THEREOF | |
| IL282411A (en) | Methods for analysis of viral capsid protein composition | |
| MX383506B (es) | Parvovirus porcino. | |
| MX378905B (es) | Pestivirus. | |
| DK3146042T3 (da) | Rekombinant klassisk svinepestvirus (CSFV) med substitution i E2-proteinets TAV-epitop | |
| PH12017501100A1 (en) | Recombinant swinepox virus and vaccines | |
| EA201990955A1 (ru) | Разработка капсидов aav | |
| BR112019001737A2 (pt) | expressão de pten-long com vírus oncolíticos | |
| HK40009350A (en) | Novel adeno-associated virus capsid proteins | |
| EA201890595A1 (ru) | Онколитический аденовирус, кодирующий белок b7 |